CYP1A2 rs762551 polymorphism and risk for amyotrophic lateral sclerosis
- PMID: 32592103
- DOI: 10.1007/s10072-020-04535-x
CYP1A2 rs762551 polymorphism and risk for amyotrophic lateral sclerosis
Abstract
Background: Genetic variability is considered to confer susceptibility to amyotrophic lateral sclerosis (ALS). Oxidative stress is a significant contributor to ALS-related neurodegeneration, and it is regulated by cytochromes P450 (CYPs), such as CYP1A2; these are responsible for the oxidative metabolism of both exogenous and endogenous substrates in the brain, subsequently impacting ALS. The function of CYP1A2 is largely affected by genetic variability; however, the impact of CYP1A2 polymorphisms in ALS remains underinvestigated.
Objective: This study aims to examine the possible association of ALS with the CYP1A2 rs762551 polymorphism, which codes for the high inducibility form of the enzyme.
Methods: One hundred and fifty-five patients with sporadic ALS and 155 healthy controls were genotyped for the CYP1A2 rs762551. Statistical testing for the association of CYP1A2 rs762551 with risk for ALS was performed using SNPstats.
Results: The CYP1A2 rs762551 C allele was associated with a decreased risk of ALS development. In the subgroup analysis according to the ALS site of onset, an association between CYP1A2 rs762551 and limb and bulbar onset of ALS was shown. Cox proportional-hazard regression analyses revealed a significant effect of the CYP1A2 rs762551 on the age of onset of ALS.
Conclusions: Based on our results, a primarily potential link between the CYP1A2 rs762551 polymorphism and ALS risk could exist.
Keywords: ALS; CYP1A2; Oxidative stress; Polymorphism; rs762551.
Similar articles
-
CYP1A2 rs762551 polymorphism contributes to risk of lung cancer: a meta-analysis.Tumour Biol. 2014 Mar;35(3):2253-7. doi: 10.1007/s13277-013-1298-6. Epub 2013 Nov 29. Tumour Biol. 2014. Retraction in: Tumour Biol. 2017 Apr 20. doi: 10.1007/s13277-017-5487-6. PMID: 24293373 Retracted.
-
Unraveling the molecular significance of CYP1A2 (rs762551; c.-9-154 C>A) genetic variant on breast carcinoma susceptibility: Insights from case-control study and meta-analysis.Pathol Res Pract. 2024 Sep;261:155501. doi: 10.1016/j.prp.2024.155501. Epub 2024 Aug 5. Pathol Res Pract. 2024. PMID: 39116569
-
Current evidence on the relationship between three polymorphisms in the CYP1A2 gene and the risk of cancer.Eur J Cancer Prev. 2013 Nov;22(6):607-19. doi: 10.1097/CEJ.0b013e32835f3bd2. Eur J Cancer Prev. 2013. PMID: 23462460
-
Meta-analysis of the association between ZNF512B polymorphism rs2275294 and risk of amyotrophic lateral sclerosis.Neurol Sci. 2018 Jul;39(7):1261-1266. doi: 10.1007/s10072-018-3411-5. Epub 2018 May 1. Neurol Sci. 2018. PMID: 29713939 Review.
-
The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic review and meta-analysis.Pharmacogenomics J. 2018 Dec;18(6):760-768. doi: 10.1038/s41397-017-0011-3. Epub 2017 Dec 27. Pharmacogenomics J. 2018. PMID: 29282363
Cited by
-
Analysis of ADORA2A rs5760423 and CYP1A2 rs762551 Genetic Variants in Patients with Alzheimer's Disease.Int J Mol Sci. 2022 Nov 19;23(22):14400. doi: 10.3390/ijms232214400. Int J Mol Sci. 2022. PMID: 36430879 Free PMC article.
-
A novel variant in DYNC1H1 could contribute to human amyotrophic lateral sclerosis-frontotemporal dementia spectrum.Cold Spring Harb Mol Case Stud. 2022 Mar 24;8(2):a006096. doi: 10.1101/mcs.a006096. Print 2022 Feb. Cold Spring Harb Mol Case Stud. 2022. PMID: 34535505 Free PMC article. Review.
-
Gene prediction of aging-related diseases based on DNN and Mashup.BMC Bioinformatics. 2021 Dec 17;22(1):597. doi: 10.1186/s12859-021-04518-5. BMC Bioinformatics. 2021. PMID: 34920719 Free PMC article.
-
Lack of an association between SCFD1 rs10139154 polymorphism and amyotrophic lateral sclerosis.Mol Med Rep. 2022 Apr;25(4):146. doi: 10.3892/mmr.2022.12662. Epub 2022 Mar 2. Mol Med Rep. 2022. PMID: 35234271 Free PMC article.
-
MOBP rs616147 Polymorphism and Risk of Amyotrophic Lateral Sclerosis in a Greek Population: A Case-Control Study.Medicina (Kaunas). 2021 Dec 7;57(12):1337. doi: 10.3390/medicina57121337. Medicina (Kaunas). 2021. PMID: 34946282 Free PMC article.
References
-
- Morgan S, Orrell RW (2016) Pathogenesis of amyotrophic lateral sclerosis. Br Med Bull 119(1):87–98. https://doi.org/10.1093/bmb/ldw026 - DOI - PubMed
-
- Chelstowska B, Kuzma-Kozakiewicz M (2020) Biochemical parameters in determination of nutritional status in amyotrophic lateral sclerosis. Neurol Sci Off J Italian Neurol Soc Italian Soc Clin Neurophysiol 41:1115–1124. https://doi.org/10.1007/s10072-019-04201-x - DOI
-
- Tarlarini C, Greco LC, Lizio A, Gerardi F, Sansone VA, Lunetta C (2019) Taste changes in amyotrophic lateral sclerosis and effects on quality of life. Neurol Sci Off J Italian Neurol Soc Italian Soc Clin Neurophysiol 40(2):399–404. https://doi.org/10.1007/s10072-018-3672-z - DOI
-
- Crockford C, Newton J, Lonergan K, Chiwera T, Booth T, Chandran S, Colville S, Heverin M, Mays I, Pal S, Pender N, Pinto-Grau M, Radakovic R, Shaw CE, Stephenson L, Swingler R, Vajda A, Al-Chalabi A, Hardiman O, Abrahams S (2018) ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology 91(15):e1370–e1380. https://doi.org/10.1212/wnl.0000000000006317 - DOI - PubMed - PMC
-
- Pupillo E, Messina P, Logroscino G, Beghi E (2014) Long-term survival in amyotrophic lateral sclerosis: a population-based study. Ann Neurol 75(2):287–297. https://doi.org/10.1002/ana.24096 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous